Twenty six of the 27 patients 96.3% who developed CKD in the first six months following hepatic transplant were treated with Cyclosporin A while only one 3.7% was treated with tacrolimus See Table 4.
De los 27 pacientes que desarrollaron falla renal crónica a los seis meses de seguimiento, 26 96,3% recibieron en el postrasplante inmediato ciclosporina A y uno 3,7% tacrolimus tabla 4.